
A VC fund for future scientist-CEOs… by scientist-CEOs. 🚀 | GPs: @bigaxon & @monicaberrondo | Become an LP: https://xitter.gq/t.co/NP7C1Smjkh
Los Angeles, CA
Joined November 2021
- Tweets135
- Following61
- Followers189
- Likes473
Brazen Capital retweeted
Sad it takes someone being diagnosed with glioblastoma to finally get traction with institutional investors.
Still, super happy to have YC join the fight. ✊🏽
@curemotive #FuckGlioblastoma
The rate of gliomas— or brain cancer— is exploding. Over the last ten years, there have been 5x as many cases.
There's so much more that we could do against this disease, and we'd love to be a part of the fight against it. @SurbhiSarnaSF
Brazen Capital retweeted
Interested in learning more about Venture Capital? Register for the “VC Night” webinar on Thursday November 30th at 4 PM PT / 7 PM ET hosted by @Accel @BainCapVC @BessemerVP @BatteryVentures and Spectrum. Register here: rb.gy/s9irz
Brazen Capital retweeted
“I think the main value prop that a VC has to offer a founder is advice. And if you’ve never walked in the founders shoes before, if you’ve never founded a company—or at least had a significant operating role —how are you in a position to offer them advice?” @DavidSacks ✊🏽
Brazen Capital retweeted
Woo! Another batch brewing… YC S23 👀
@BrazenCapital @ycombinator
Brazen Capital retweeted
Can't believe it's already been a year that I've been writing the "VC Corner" for The House Brazeryen, @BrazenBio's bi-weekly newsletter! I also can't believe I didn't even realize that yesterday was a year 🤦♂️
Brazen Capital retweeted
Meet two first-time fund managers intent on shaking up the world of #biotech #venturecapital 🦄
.
linkedin.com/posts/bigaxon_b…
.
@BrazenCapital @monicaberrondo @bigaxon
Brazen Capital retweeted
It’s that 🧡special🧡 time of year again! @BrazenCapital – at Los Angeles, CA
Brazen Capital retweeted
"Building a therapeutics startup ✨WITHOUT✨ VC?!!?!"
Read all about that, Venture Fellows, the lack of diversity in VC funding, AND MORE in the latest issue of Brazen Bio's newsletter: The House Brazeryen 🐉
open.substack.com/pub/brazen…
@BrazenCapital @bigaxon #biotech #startup
Brazen Capital retweeted
Biotech VC is broken. I raised $20M in funding and developed my therapeutic idea into a clinical stage drug ONE ANGEL INVESTOR CHECK AT A TIME (no VC). 💪🏽
Patients are waiting. Which biotech investors will join the #scientistCEO movement?
@BrazenBio @BrazenCapital #BeBrazen
Brazen Capital retweeted
Monica and I are scientist-CEOs looking to support the next generation of scientist-CEOs through @BrazenCapital!! 🚀
Join our mission: brazen.capital #biotech #startup
Brazen Capital retweeted
Ananya is the first CEO @monicaberrondo and I invested in through @BrazenCapital 🚀
.
Her startup guardian-bio.com is doing the brazen science that many others won’t back. She’s our people. 🦄 #JPM2023 #biotech
Brazen Capital retweeted
The latest from The House Brazeryen 🐉
This issue: The Dropouts Channel, JPM, "inflammaging"
brazen.substack.com/p/the-ho…
@BrazenCapital @bigaxon
Brazen Capital retweeted
Replying to @anirudhsud1
None of that is even vaguely relevant to advancing medicine for patients. That’s what excites me every year. ✊🏽😤
Brazen Capital retweeted
Love meeting with amazing founders IRL!!! 🤎💙💜
.
These are the 1st two investments my VC fund @BrazenCapital made this year: @heymalama and Guardian Bio (no tweeter 😭), both woman-led ✊🏽
.
What other women-led bio startups we should we be looking at? 🚀
.
#biotech #startup #VC
Brazen Capital retweeted
I'm lucky enough to know @bigaxon and his journey. University bureaucracy wasn't going to hold him back. He said "Screw it", did it himself, and is paying it forward w/ @BrazenBio & @BrazenCapital.
Read how he's fueling the rise of the scientist-CEO and get inspired! #BeBrazen
How do we fuel the rise of the scientist-CEO? 🚀
Glad you asked... @BryReinhardt and I just published this piece in @GENBiotechJrnl liebertpub.com/doi/10.1089/g…
Brazen Capital retweeted
How do we fuel the rise of the scientist-CEO? 🚀
Glad you asked... @BryReinhardt and I just published this piece in @GENBiotechJrnl liebertpub.com/doi/10.1089/g…



















